The following represents disclosure information provided by authors of this abstract. The ASCO-NCI-EORTC Annual Meeting on Molecular Markers in Cancer Planning Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Decrease in CA-19-9 after neoadjuvant chemoradiation therapy to predict survival in locally advanced pancreatic cancer.
Jaswinder Singh
No relevant relationships to disclose
Syed Faisal Jafri
No relevant relationships to disclose
Maninder Pabla
No relevant relationships to disclose
Bradley L. Freilich
No relevant relationships to disclose
Joe Cates
No relevant relationships to disclose
John M. Sheldon
No relevant relationships to disclose
David Shaeffer
No relevant relationships to disclose
Michael Connor
No relevant relationships to disclose
Raj Shah
No relevant relationships to disclose
Reed Cope
No relevant relationships to disclose
Niharika Rath
No relevant relationships to disclose
Michael Burt
No relevant relationships to disclose
Srijita Mukherjee
No relevant relationships to disclose
Unnati Parikh
No relevant relationships to disclose
Jennifer Wanpen Feeback
No relevant relationships to disclose